In many experimental murine models, the fusion protein used alone or in combination with checkpoint inhibitors, such as anti-PD-1 Abs, delays tumor growth, can induce tumor regression and prolongs survival in mice (66). This evidence concerns the gene PDCD1 and neoplasm.